Skip to content
Coming Soon·Opens soon·Synced from source July 6, 2026

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

National Institutes of Health

Posted
Jan 29, 2026
Closes
No deadline published by the funder
Last verified
Jul 6, 2026

Classification and identifiers

Solicitation number
RFA-DK-27-112
Assistance listing (CFDA)
93.847

Amount

Amount not published by the funder

Who can apply

Private universitiesPublic universities

This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

About this opportunity

The primary purpose of this FOA is to support the EDIC Research Center in continuing long-term follow-up of the EDIC cohort to study the development and progression of complications in type 1 diabetes (T1D). The research will address severe microvascular disease, cardiovascular and liver disease, sleep disorders, mortality, and other comorbidities. The goals are to investigate the trajectory of age-related morbidities such as cognition, physical function, and frailty, and to identify their associations with risk factors that affect quality of life, self-management, and caregiver burden. Particular emphasis will be placed on evaluating the impact of emerging therapies, including SGLT2 inhibitors and GLP-1 receptor agonists, on renal and cardiovascular outcomes. The initiative also encourage...

Finding similar opportunities...